Inventor · disambiguated record
Philippe Wolgen
Also filed as: WOLGEN PHILIPPE
6 granted patents·11 pending applications·16 citations·filing 2001–2021
76Inventor score
Files withCLINUVEL PHARMACEUTICALS LTD6VALLAURIX PTE LTD3WOLGEN PHILIPPE3CLINUVEL AG2CLINUVEL UK LTD1
Top patents by PatentIndex Score
17 records- 0172US11286288B2Pharmaceutical compoundVALLAURIX PTE LTD·Filed 2019·Granted Mar 29, 2022·1 cites·11 claims
- 0267US10508142B2Pharmaceutical compoundVALLAURIX PTE LTD·Filed 2016·Granted Dec 17, 2019·1 cites·8 claims
- 0367US9801924B2Therapy for vitiligoCLINUVEL PHARMACEUTICALS LTD·Filed 2013·Granted Oct 31, 2017·1 cites·9 claims
- 0463US11622994B2Therapy for vitiligoCLINUVEL PHARMACEUTICALS LTD·Filed 2017·Granted Apr 11, 2023·0 cites·11 claims
- 0562US8334265B2Method of treatment of photodermatosesWOLGEN PHILIPPE·Filed 2007·Granted Dec 18, 2012·1 cites·4 claims
- 0658US2011130705A1Therapy for vitiligoCLINUVEL PHARMACEUTICALS LTD·Filed 2009·Application pending·0 cites
- 0752US2023355598A1Pyrrolidine compounds to treat xeroderma pigmentosumCLINUVEL UK LTD·Filed 2021·Application pending·0 cites
- 0850US2010113337A1Method for reducing incidence or rate of development of skin cancers and related conditionsCLINUVEL PHARMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 0948US2023101963A1Treatment of medical indicationVALLAURIX TRADING SARL MC·Filed 2021·Application pending·0 cites
- 1046US7252668B2Distraction device for maxillofacial surgeryFACEWORKS SOLUTIONS & TECHNOLO·Filed 2001·Granted Aug 7, 2007·12 cites·14 claims
- 1146US2013344153A1Method for reducing incidence or rate of development of skin cancers and related conditionsCLINUVEL PHARMACEUTICALS LTD·Filed 2013·Application pending·0 cites
- 1243US2020246436A1Alpha-msh analogues used in the treatment of xeroderma pigmentosumCLINUVEL PHARMACEUTICALS LTD·Filed 2018·Application pending·0 cites
- 1337US2013331331A1Hexapeptide with improved activity in the repair of cellular dna of dermal cellsWOLGEN PHILIPPE·Filed 2012·Application pending·0 cites
- 1436US2017360896A1Inflammatory diseaseCLINUVEL AG·Filed 2015·Application pending·0 cites
- 1532US2018086789A1Pharmaceutical compoundVALLAURIX PTE LTD·Filed 2016·Application pending·0 cites
- 1630US2017304406A1New indication for alpha-msh analoguesCLINUVEL AG·Filed 2015·Application pending·0 cites
- 1729US2006122606A1Radial osteogenic distractor deviceWOLGEN PHILIPPE·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Philippe Wolgen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →